Income Statement (TTM)
Entrada Therapeutics, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25 | 43 | 87 | 129 | 163 | 239 | 215 | 211 | 172 | 79 |
| Change (%) | 71.93 | 100.70 | 48.01 | 26.25 | 46.98 | -10.09 | -2.07 | -18.29 | -53.85 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 74 | 84 | 87 | 100 | 105 | 111 | 120 | 125 | 129 | 135 |
| Change (%) | 13.59 | 3.85 | 14.44 | 5.51 | 5.44 | 8.16 | 4.26 | 2.77 | 4.54 | |
| % of Revenue | 292.93 | 193.52 | 100.13 | 77.42 | 64.71 | 46.42 | 55.84 | 59.45 | 74.77 | 169.38 |
| Gross Operating Profit | -49 | -41 | -0 | 29 | 57 | 128 | 95 | 85 | 43 | -55 |
| Change (%) | -16.66 | -99.72 | -25,877.88 | 97.34 | 123.15 | -25.91 | -10.06 | -49.17 | -226.91 | |
| % of Revenue | -192.93 | -93.52 | -0.13 | 22.58 | 35.29 | 53.58 | 44.16 | 40.55 | 25.23 | -69.38 |
| SG&A | 32 | 33 | 34 | 32 | 34 | 35 | 37 | 38 | 39 | 41 |
| Change (%) | 2.60 | 1.68 | -3.70 | 4.52 | 3.16 | 7.00 | 3.24 | 2.27 | 4.29 | |
| % of Revenue | 127.25 | 75.94 | 38.47 | 25.03 | 20.72 | 14.54 | 17.31 | 18.25 | 22.84 | 51.62 |
| R&D | ||||||||||
| Change (%) | ||||||||||
| % of Revenue | ||||||||||
| OpEx | 106 | 117 | 121 | 132 | 139 | 146 | 157 | 164 | 168 | 176 |
| Change (%) | 10.26 | 3.24 | 9.41 | 5.27 | 4.89 | 7.88 | 4.02 | 2.65 | 4.48 | |
| % of Revenue | 420.18 | 269.45 | 138.60 | 102.45 | 85.43 | 60.96 | 73.15 | 77.70 | 97.61 | 221.00 |
| Operating Income | -81 | -74 | -34 | -3 | 24 | 93 | 58 | 47 | 4 | -96 |
| Change (%) | -9.01 | -54.28 | -90.60 | -850.51 | 293.80 | -38.17 | -18.64 | -91.26 | -2,440.90 | |
| % of Revenue | -320.18 | -169.45 | -38.60 | -2.45 | 14.57 | 39.04 | 26.85 | 22.30 | 2.39 | -121.00 |
| Interest Expense | ||||||||||
| Change (%) | ||||||||||
| % of Revenue | ||||||||||
| Net Income | -80 | -82 | -22 | -7 | 23 | 104 | 55 | 66 | 25 | -73 |
| Change (%) | 3.45 | -73.57 | -69.29 | -451.31 | 344.73 | -47.39 | 19.43 | -62.24 | -396.01 | |
| % of Revenue | -315.20 | -189.66 | -24.98 | -5.18 | 14.42 | 43.63 | 25.53 | 31.13 | 14.39 | -92.30 |
Source: Capital IQ
